CAS No.: 138926-19-9
Ibandronate sodium monohydrate/伊班膦酸钠 Catalog No. CSN12541
Synonyms: BM-21.0955;BM 210955;Ibandronate (sodium hydrate)
Ibandronate sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Epplen R, Stockle M, et al. Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol. 2011 Jan;50(1):127-33.
- [2] Morgan C, Jeremiah S, Wagstaff J. Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res. 2009 Dec;78(3):453-8.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 138926-19-9 | 储存条件 |
|
|||||
| 分子式 | C9H24NNaO8P2 | 运输 | 蓝冰 | |||||
| 分子量 | 359.23 | 别名 | BM-21.0955;BM 210955;Ibandronate (sodium hydrate);Boniva;Ibandronate sodium;Sodium trihydrogen (1-hydroxy-3-(methylpentylamino)propylidene)diphosphonate;monohydrate;伊班膦酸钠一水合物;RPR-102289A | |||||
| 溶解度 |
|
动物实验配方 |
